244 related articles for article (PubMed ID: 25513956)
1. Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.
Ma F; Nan K; Lee S; Beadle JR; Hou H; Freeman WR; Hostetler KY; Cheng L
Eur J Pharm Biopharm; 2015 Jan; 89():271-9. PubMed ID: 25513956
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
[TBL] [Abstract][Full Text] [Related]
3. Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.
Wang H; Chhablani J; Freeman WR; Beadle JR; Hostetler KY; Hartmann K; Conner L; Aldern KA; Pearson L; Cheng L
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9391-6. PubMed ID: 22058340
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
[TBL] [Abstract][Full Text] [Related]
5. Intraocular properties of hexadecyloxypropyl-cyclic-cidofovir in Guinea pigs.
Lu S; Cheng L; Hostetler KY; Koh HJ; Beadle JR; Davidson MC; Freeman WR
J Ocul Pharmacol Ther; 2005 Jun; 21(3):205-9. PubMed ID: 15969637
[TBL] [Abstract][Full Text] [Related]
6. Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
Kuppermann BD; Assil KK; Vuong C; Besen G; Wiley CA; De Clercq E; Bergeron-Lynn G; Connor JD; Pursley M; Munguia D; Freeman WR
J Infect Dis; 1996 Jan; 173(1):18-23. PubMed ID: 8537656
[TBL] [Abstract][Full Text] [Related]
7. A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.
Kim JS; Beadle JR; Freeman WR; Hostetler KY; Hartmann K; Valiaeva N; Kozak I; Conner L; Trahan J; Aldern KA; Cheng L
Mol Vis; 2012; 18():1907-17. PubMed ID: 22876115
[TBL] [Abstract][Full Text] [Related]
8. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Toyoguchi M; Bergeron-Lynn G; Freeman WR
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):515-21. PubMed ID: 11818399
[TBL] [Abstract][Full Text] [Related]
9. Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.
Bravo FJ; Bernstein DI; Beadle JR; Hostetler KY; Cardin RD
Antimicrob Agents Chemother; 2011 Jan; 55(1):35-41. PubMed ID: 21078944
[TBL] [Abstract][Full Text] [Related]
10. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA
Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758
[TBL] [Abstract][Full Text] [Related]
11. A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation.
Chen M; Hou J; Tan G; Xie P; Freeman WR; Beadle JR; Hostetler KY; Cheng L
Drug Deliv; 2017 Nov; 24(1):1703-1712. PubMed ID: 29115885
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal crystalline drug delivery for intraocular proliferation diseases.
Cheng L; Hostetler K; Valiaeva N; Tammewar A; Freeman WR; Beadle J; Bartsch DU; Aldern K; Falkenstein I
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):474-81. PubMed ID: 19696179
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine.
Ruiz J; Beadle JR; Buller RM; Schreiwer J; Prichard MN; Keith KA; Lewis KC; Hostetler KY
Bioorg Med Chem; 2011 May; 19(9):2950-8. PubMed ID: 21493074
[TBL] [Abstract][Full Text] [Related]
14. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
Aldern KA; Ciesla SL; Winegarden KL; Hostetler KY
Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
Ruiz JC; Beadle JR; Aldern KA; Keith KA; Hartline CB; Kern ER; Hostetler KY
Antiviral Res; 2007 Jul; 75(1):87-90. PubMed ID: 17367874
[TBL] [Abstract][Full Text] [Related]
16. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
Taskintuna I; Banker AS; Rao NA; Wiley CA; Flores-Aguilar M; Munguia D; Bergeron-Lynn G; De Clercq E; Keefe K; Freeman WR
Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910
[TBL] [Abstract][Full Text] [Related]
17. Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection.
Bidanset DJ; Beadle JR; Wan WB; Hostetler KY; Kern ER
J Infect Dis; 2004 Aug; 190(3):499-503. PubMed ID: 15243923
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis.
Cheng L; Beadle JR; Tammewar A; Hostetler KY; Hoh C; Freeman WR
J Ocul Pharmacol Ther; 2011 Apr; 27(2):157-62. PubMed ID: 21351867
[TBL] [Abstract][Full Text] [Related]
19. Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pig.
Tammewar AM; Cheng L; Hostetler KY; Falkenstein I; Beadle JR; Barron EC; Kozak I; Freeman WR
J Ocul Pharmacol Ther; 2007 Oct; 23(5):433-44. PubMed ID: 17900229
[TBL] [Abstract][Full Text] [Related]
20. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
